Comments
Loading...

Lexicon Pharmaceuticals

LXRXNASDAQ
Logo brought to you by Benzinga Data
$1.69
0.053.05%
At Close: -
$1.69
~00.01%
After Hours: 7:12 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$3.00
Consensus Price Target1
$7.20

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock, Analyst Ratings, Price Targets, Forecasts

Lexicon Pharmaceuticals Inc has a consensus price target of $7.2 based on the ratings of 6 analysts. The high is $10 issued by HC Wainwright & Co. on September 11, 2024. The low is $3 issued by Jefferies on March 7, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on September 11, 2024, September 3, 2024, and August 21, 2024, respectively. With an average price target of $10 between HC Wainwright & Co., there's an implied 491.68% upside for Lexicon Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Jun
0
0
0
0
Jul
0
0
0
0
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Leerink Partners
Citigroup
Jefferies
Piper Sandler

1calculated from analyst ratings

Analyst Ratings for Lexicon Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Lexicon Pharmaceuticals (LXRX) stock?

A

The latest price target for Lexicon Pharmaceuticals (NASDAQ:LXRX) was reported by HC Wainwright & Co. on September 11, 2024. The analyst firm set a price target for $10.00 expecting LXRX to rise to within 12 months (a possible 491.68% upside). 13 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Lexicon Pharmaceuticals (LXRX)?

A

The latest analyst rating for Lexicon Pharmaceuticals (NASDAQ:LXRX) was provided by HC Wainwright & Co., and Lexicon Pharmaceuticals reiterated their buy rating.

Q

When was the last upgrade for Lexicon Pharmaceuticals (LXRX)?

A

There is no last upgrade for Lexicon Pharmaceuticals

Q

When was the last downgrade for Lexicon Pharmaceuticals (LXRX)?

A

There is no last downgrade for Lexicon Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Lexicon Pharmaceuticals (LXRX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lexicon Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lexicon Pharmaceuticals was filed on September 11, 2024 so you should expect the next rating to be made available sometime around September 11, 2025.

Q

Is the Analyst Rating Lexicon Pharmaceuticals (LXRX) correct?

A

While ratings are subjective and will change, the latest Lexicon Pharmaceuticals (LXRX) rating was a reiterated with a price target of $10.00 to $10.00. The current price Lexicon Pharmaceuticals (LXRX) is trading at is $1.69, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch